Occidental Asset Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $419K | Hold |
11,642
| – | – | 0.06% | 159 |
|
|
2025
Q1 | $459K | Buy |
11,642
+19
| +0.2% | +$749 | 0.07% | 140 |
|
|
2024
Q4 | $350K | Hold |
11,623
| – | – | 0.05% | 153 |
|
|
2024
Q3 | $272K | Hold |
11,623
| – | – | 0.04% | 178 |
|
|
2024
Q2 | $207K | Hold |
11,623
| – | – | 0.04% | 193 |
|
|
2024
Q1 | $177K | Hold |
11,623
| – | – | 0.03% | 194 |
|
|
2023
Q4 | $199K | Hold |
11,623
| – | – | 0.04% | 198 |
|
|
2023
Q3 | $97.2K | Hold |
11,623
| – | – | 0.02% | 198 |
|
|
2023
Q2 | $289K | Hold |
11,623
| – | – | 0.07% | 178 |
|
|
2023
Q1 | $175K | Hold |
11,623
| – | – | 0.04% | 194 |
|
|
2022
Q4 | $138K | Hold |
11,623
| – | – | 0.04% | 197 |
|
|
2022
Q3 | $69K | Hold |
11,623
| – | – | 0.02% | 179 |
|
|
2022
Q2 | $49K | Hold |
11,623
| – | – | 0.01% | 178 |
|
|
2022
Q1 | $111K | Hold |
11,623
| – | – | 0.03% | 188 |
|
|
2021
Q4 | $221K | Hold |
11,623
| – | – | 0.05% | 193 |
|
|
2021
Q3 | $387K | Hold |
11,623
| – | – | 0.1% | 157 |
|
|
2021
Q2 | $451K | Sell |
11,623
-8,077
| -41% | -$313K | 0.12% | 149 |
|
|
2021
Q1 | $950K | Buy |
+19,700
| New | +$950K | 0.28% | 94 |
|